These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33381588)
1. Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A Meta-Analysis. Li J; Yin J; Zhong J; Yang Z; Tang A; Li S Biomed Res Int; 2020; 2020():8828579. PubMed ID: 33381588 [TBL] [Abstract][Full Text] [Related]
2. Expression of MCSP and PRAME in conjunctival melanoma. Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Meller D; Zeschnigk M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F Br J Ophthalmol; 2010 Oct; 94(10):1322-7. PubMed ID: 20805128 [TBL] [Abstract][Full Text] [Related]
3. Prognostic and Clinicopathological Value of PD-L1 in Melanoma: A Meta-Analysis. Xu J; Wang F; Yan Y; Zhang Y; Du Y; Sun G Am J Med Sci; 2020 Jun; 359(6):339-346. PubMed ID: 32498941 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis. Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912 [TBL] [Abstract][Full Text] [Related]
5. The effect of preferentially expressed antigen in melanoma (PRAME) expression status on survival in stage II and stage III colon cancer. Ogul A; Paydas S; Doran F; Erdogan KE; Tohumcuoglu M; Buyuksimsek M; Mirili C; Yetisir AE J BUON; 2021; 26(3):992-1001. PubMed ID: 34268964 [TBL] [Abstract][Full Text] [Related]
6. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1. Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576 [TBL] [Abstract][Full Text] [Related]
7. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells. Lee YK; Park UH; Kim EJ; Hwang JT; Jeong JC; Um SJ Cancer Lett; 2017 Sep; 403():144-151. PubMed ID: 28634046 [TBL] [Abstract][Full Text] [Related]
8. Baba H; Kanda M; Sawaki K; Shimizu D; Umeda S; Koike M; Kodera Y; Fujii T Anticancer Res; 2019 Nov; 39(11):5943-5951. PubMed ID: 31704819 [TBL] [Abstract][Full Text] [Related]
9. 15-Gene Expression Profile and Harbour JW; Correa ZM; Schefler AC; Mruthyunjaya P; Materin MA; Aaberg TA; Skalet AH; Reichstein DA; Weis E; Kim IK; Fuller TS; Demirci H; Piggott KD; Williams BK; Shildkrot E; Capone A; Oliver SC; Walter SD; Mason J; Char DH; Altaweel M; Wells JR; Duker JS; Hovland PG; Gombos DS; Tsai T; Javid C; Marr BP; Gao A; Decatur CL; Dollar JJ; Kurtenbach S; Zhang S J Clin Oncol; 2024 Oct; 42(28):3319-3329. PubMed ID: 39052972 [TBL] [Abstract][Full Text] [Related]
10. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of LINC00460 overexpression in solid tumours: a meta-analysis. Dai C; Zhang Y; Ni H; Kuang Y; Xu Z Postgrad Med J; 2020 May; 96(1135):286-295. PubMed ID: 32054779 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic and predictive relevance of PRAME in breast cancer. Doolan P; Clynes M; Kennedy S; Mehta JP; Crown J; O'Driscoll L Breast Cancer Res Treat; 2008 May; 109(2):359-65. PubMed ID: 17624586 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas. Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988 [TBL] [Abstract][Full Text] [Related]
14. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer. Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640 [TBL] [Abstract][Full Text] [Related]
15. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320 [TBL] [Abstract][Full Text] [Related]
17. PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer. Cassalia F; Danese A; Tudurachi I; Federico S; Zambello A; Guidotti A; Franceschin L; Bolzon A; Naldi L; Belloni Fortina A Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338862 [TBL] [Abstract][Full Text] [Related]
18. Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma. Qin Y; Lu J; Bao L; Zhu H; Li J; Li L; Lai Y; Shi H; Wang Y; Liu Y; Jiang B; Huang X Chin Med J (Engl); 2014; 127(9):1666-71. PubMed ID: 24791872 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a series of 85 cases. Broggi G; Failla M; Russo A; Longo A; Palicelli A; Zanelli M; Lombardo C; Loreto C; Merolla F; Di Crescenzo RM; Ilardi G; Varricchio S; Staibano S; Caltabiano R Pathol Res Pract; 2023 Jul; 247():154543. PubMed ID: 37210771 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of long non-coding RNA UCA1 in human solid tumors. Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]